PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,632 | -62.8% | 42,390 | +29.8% | 0.00% | – |
| Q4 2022 | $33,965 | -21.0% | 32,659 | -13.5% | 0.00% | – |
| Q3 2022 | $43,000 | -89.6% | 37,759 | -72.2% | 0.00% | -100.0% |
| Q1 2022 | $412,000 | -89.4% | 135,876 | -86.8% | 0.00% | -87.5% |
| Q4 2021 | $3,885,000 | -35.6% | 1,027,825 | -12.0% | 0.01% | -38.5% |
| Q3 2021 | $6,036,000 | +6533.0% | 1,167,548 | +3195.5% | 0.01% | – |
| Q1 2021 | $91,000 | -33.6% | 35,429 | -35.5% | 0.00% | – |
| Q4 2020 | $137,000 | +495.7% | 54,968 | +399.5% | 0.00% | – |
| Q3 2020 | $23,000 | -90.9% | 11,004 | -86.5% | 0.00% | -100.0% |
| Q2 2020 | $253,000 | +141.0% | 81,459 | +77.5% | 0.00% | 0.0% |
| Q1 2020 | $105,000 | -74.5% | 45,883 | -59.6% | 0.00% | 0.0% |
| Q4 2019 | $411,000 | +323.7% | 113,527 | +290.4% | 0.00% | – |
| Q1 2019 | $97,000 | -39.0% | 29,083 | -51.5% | 0.00% | -100.0% |
| Q4 2018 | $159,000 | +31.4% | 59,950 | +151.4% | 0.00% | – |
| Q2 2018 | $121,000 | -83.5% | 23,845 | -75.5% | 0.00% | -100.0% |
| Q4 2017 | $734,000 | – | 97,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |